Inspire Medical Systems, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $912.0 | $802.8 | $624.8 | $407.9 | $233.4 |
| Operating income | $51.0 | $36.1 | -$40.3 | -$47.6 | -$39.9 |
| Net income | $145.4 | $53.5 | -$21.2 | -$44.9 | -$42.0 |
| Cash Flow Statement | |||||
| Free cash flow | $78.5 | $91.1 | $1.0 | $2.5 | -$24.8 |
| Share repurchases | $175.0 | $0.0 | $0.0 | $0.0 | — |
Shares outstanding 28.9M · Free float 92.6%
Annual filing data through FY ended December 31, 2025; float as of October 1, 2026.
Earnings
Other Coverage
October 14, 2026
Theme Survey
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground